Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
As of Nov 13, 2026, ANDA 90866 (Valsartan), held by Mylan, was first approved by FDA on Jan 5, 2015, with 3 approved supplements and 0 published complete response letters.
First approved: Jan 5, 2015
Supplements approved: 3
Complete response letters: 0
Approvals and New Uses
The original application and every efficacy supplement, newest first; all 4 submissions below
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters.Drugs@FDA and FDA complete response letters
